BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31600638)

  • 1. Protective effects of zinc on rat sperm chromatin integrity involvement: DNA methylation, DNA fragmentation, ubiquitination and protamination after bleomycin etoposide and cis-platin treatment.
    Khadivi F; Razavi S; Hashemi F
    Theriogenology; 2020 Jan; 142():177-183. PubMed ID: 31600638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Protective Effects of Omega3 on Ubiquitination and Protamination of Rat Sperm after Bleomycin, Etoposide, and Cisplatin Treatment.
    Hashemi F; Razavi S; Khadivi F
    Nutr Cancer; 2018; 70(8):1308-1314. PubMed ID: 30477350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to bleomycin, etoposide, and cis-platinum alters rat sperm chromatin integrity and sperm head protein profile.
    Maselli J; Hales BF; Chan P; Robaire B
    Biol Reprod; 2012 May; 86(5):166, 1-10. PubMed ID: 22402960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the chemotherapy cocktail used to treat testicular cancer on sperm chromatin integrity.
    Delbes G; Hales BF; Robaire B
    J Androl; 2007; 28(2):241-9; discussion 250-1. PubMed ID: 17021337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of chemotherapy with bleomycin, etoposide, and cis-platinum (BEP) on rat sperm chromatin remodeling, fecundity and testicular gene expression in the progeny.
    Maselli J; Hales BF; Robaire B
    Biol Reprod; 2013 Oct; 89(4):85. PubMed ID: 23986570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chemotherapy and radiotherapy for testicular germ cell tumors on spermatogenesis and sperm DNA: a multicenter prospective study from the CECOS network.
    Bujan L; Walschaerts M; Moinard N; Hennebicq S; Saias J; Brugnon F; Auger J; Berthaut I; Szerman E; Daudin M; Rives N
    Fertil Steril; 2013 Sep; 100(3):673-80. PubMed ID: 23755953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
    Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
    Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic alterations in sperm DNA associated with testicular cancer treatment.
    Chan D; Delbès G; Landry M; Robaire B; Trasler JM
    Toxicol Sci; 2012 Feb; 125(2):532-43. PubMed ID: 22076425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Rat Sperm Chromatin Integrity and Spermatogenesis with Omega 3 following Bleomycin, Etoposide and Cisplatin Treatment.
    Razavi S; Hashemi F; Khadivi F; Bakhtiari A; Mokhtarian A; Mirzaei H
    Nutr Cancer; 2021; 73(3):514-522. PubMed ID: 32321280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paternal exposure to testis cancer chemotherapeutics alters sperm fertilizing capacity and affects gene expression in the eight-cell stage rat embryo.
    Maselli J; Hales BF; Robaire B
    Andrology; 2014 Mar; 2(2):259-66. PubMed ID: 24478030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
    Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants enhance the recovery of three cycles of bleomycin, etoposide, and cisplatin-induced testicular dysfunction, pituitary-testicular axis, and fertility in rats.
    Kilarkaje N; Mousa AM; Al-Bader MM; Khan KM
    Fertil Steril; 2013 Oct; 100(4):1151-9. PubMed ID: 23850298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats.
    Delbès G; Chan D; Pakarinen P; Trasler JM; Hales BF; Robaire B
    Biol Reprod; 2009 Feb; 80(2):320-7. PubMed ID: 18987330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics bleomycin, etoposide, and cisplatin on spermatogenesis, fertility, and progeny outcome in the male rat.
    Marcon L; Hales BF; Robaire B
    J Androl; 2008; 29(4):408-17. PubMed ID: 18296477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility.
    Bieber AM; Marcon L; Hales BF; Robaire B
    J Androl; 2006; 27(2):189-200. PubMed ID: 16278370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
    Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
    Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
    J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of sperm chromosome complements before, during, and after chemotherapy.
    Martin RH; Ernst S; Rademaker A; Barclay L; Ko E; Summers N
    Cancer Genet Cytogenet; 1999 Jan; 108(2):133-6. PubMed ID: 9973940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.